Rosty Raykov - 04 Apr 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Signature
/s/ Rostislav Raykov
Issuer symbol
FENC
Transactions as of
04 Apr 2024
Net transactions value
-$958,669
Form type
4
Filing time
05 Apr 2024, 16:56:10 UTC
Previous filing
03 Apr 2024
Next filing
02 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Sale $158,872 -14,583 -5.3% $10.89 261,471 04 Apr 2024 Direct F1
transaction FENC Common shares Sale $323,528 -29,700 -11% $10.89 231,771 04 Apr 2024 Direct F2
transaction FENC Common shares Sale $476,269 -44,300 -19% $10.75 187,471 05 Apr 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.
F2 Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.
F3 Represents shares sold pusuant to a 10b5-1 plan dated December 14, 2023.